IP Library Granted Patent US 7,670,816
Granted Patent B2
US 7,670,816 · App. 12/244,921 · Granted Mar 2, 2010

UDP-galactose:β-D-galactose-R 4-α-D-galactosyltransferase, α4gal-T1

Assignee: Glycozym USA Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,670,816
App. No.
12/244,921
Granted
Mar 2, 2010
Kind
B2
Abstract

A novel gene defining a novel enzyme UDP-galactose: β-D-galactose-R 4-α-D-galactosyltransferase, termed α4Gal-T1, with unique enzymatic properties is disclosed. The invention provides isolated DNA molecules and DNA constructs encoding α4Gal-T1 and derivatives thereof by way of amino acid deletion, substitution or insertion exhibiting α4Gal-T1 activity, as well as cloning and expression vectors including such DNA, host cells comprising DNA encoding α4Gal-T1, and recombinant methods for providing α4Gal-T1. The enzyme α4Gal-T1 and α4Gal-active derivatives thereof are disclosed. Further, the invention discloses methods of obtaining α1, 4galactosyl glycosylated glycosphingolipids by use of an enzymatically active α4Gal-T1 protein thereof or by using cells stably transfected with a vector including DNA encoding an enzymatically active α4Gal-T1 protein as an expression system for recombinant production of such glycosphingolipids. Also a method for the identification of DNA sequence variations in the α4Gal-T1-coding exon by PCR, and detecting the presence of DNA sequence variation, are disclosed.

Claims (10)

1. An isolated nucleic acid encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 11, wherein the polypeptide has UDP-galactose: β-D-galactose-R4-α-D-galactosyltransferase (α4Gal-T1) activity.

2. A nucleic acid vector comprising the nucleic acid sequence set forth in claim 1 .

3. A cell comprising the vector set forth in claim 2 .

4. The cell as defined in claim 3 , wherein the cell produces enzymatically active UDP-galactose: β-D-galactose-R4-α-D-galactosyltransferase (α4Gal-T1).

5. The cell as defined in claim 3 , wherein the cell is selected from the group consisting of bacterial, yeast, insect, avian, and mammalian cells.

6. An isolated nucleic acid comprising the nucleotide sequence of SEQ ID NO: 10, wherein the nucleic acid encodes a polypeptide having UDP-galactose: β-D-galactose-R4-α-D-galactosyltransferase (α4Gal-T1) activity.

7. A nucleic acid vector comprising the nucleic acid sequence set forth in claim 6 .

8. A cell comprising the vector set forth in claim 7 .

9. The cell as defined in claim 8 , wherein the cell produces enzymatically active UDP-galactose: β-galactose-R4-α-D-galactosyltransferase (α4Gal-T1).

10. The cell as defined in claim 8 , wherein the cell is selected from the group consisting of bacterial, yeast, insect, avian, and mammalian cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2009
From: GLYCOZYM APS
To: GLYCOZYM USA INC.
Reel/Frame 022939/0944 →
Continuity (5)
Division 1131719600 · Dec 22, 2005
Continuation 1021733500 · Aug 9, 2002
Continuation PCTDK010008700 · Feb 9, 2001
Provisional Application 6018203700 · Feb 11, 2000
Related Publication 20090104693A1 · Apr 23, 2009